These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 11012330)
1. Improvement of Huntington's disease with olanzapine and valproate. Grove VE; Quintanilla J; DeVaney GT N Engl J Med; 2000 Sep; 343(13):973-4. PubMed ID: 11012330 [No Abstract] [Full Text] [Related]
2. Combination of olanzapine and divalproex for agitation in individuals with profound mental retardation. Olson DA; Ingram W; Mann JR J Clin Psychopharmacol; 2002 Oct; 22(5):529-30. PubMed ID: 12352281 [No Abstract] [Full Text] [Related]
3. [Good effect of valproate against aggression in Huntington disease. Only two cases reported earlier]. Rask G; Andersson C Lakartidningen; 2010 Dec 1-7; 107(48):3060-1. PubMed ID: 21287753 [No Abstract] [Full Text] [Related]
4. The use of olanzapine for movement disorder in Huntington's disease: a first case report. Dipple HC J Neurol Neurosurg Psychiatry; 1999 Jul; 67(1):123-4. PubMed ID: 10454874 [No Abstract] [Full Text] [Related]
11. Brain SPECT imaging in Huntington's disease before and after therapy with olanzapine. Case report. Etchebehere EC; Lima MC; Passos W; Maciel Júnior JA; Santos AO; Ramos CD; Camargo EE Arq Neuropsiquiatr; 1999 Sep; 57(3B):863-6. PubMed ID: 10751925 [TBL] [Abstract][Full Text] [Related]
12. [Olanzapine as an alternative in clozapine-induced akathisia?]. Knoch H; Hofmann M; Seifritz E Psychiatr Prax; 1999 Nov; 26(6):308. PubMed ID: 10627963 [No Abstract] [Full Text] [Related]
13. Rapid efficacy of olanzapine augmentation in nonpsychotic bipolar mixed states. Ketter TA; Winsberg ME; DeGolia SG; Dunai M; Tate DL; Strong CM J Clin Psychiatry; 1998 Feb; 59(2):83-5. PubMed ID: 9501894 [No Abstract] [Full Text] [Related]
14. Possible risperidone-induced visual hallucinations. Solhkhah R; Finkel J; Hird S J Am Acad Child Adolesc Psychiatry; 2000 Sep; 39(9):1074-5. PubMed ID: 10986801 [No Abstract] [Full Text] [Related]
15. Olanzapine for Huntington's disease: an open label study. Bonelli RM; Mahnert FA; Niederwieser G Clin Neuropharmacol; 2002; 25(5):263-5. PubMed ID: 12410058 [TBL] [Abstract][Full Text] [Related]
16. High-dose olanzapine in Huntington's disease. Bonelli RM; Niederwieser G; Tribl GG; Költringer P Int Clin Psychopharmacol; 2002 Mar; 17(2):91-3. PubMed ID: 11890191 [TBL] [Abstract][Full Text] [Related]
17. Treatment of bipolar I disorder in an adolescent with olanzapine. Khouzam HR; El-Gabalawi F J Child Adolesc Psychopharmacol; 2000; 10(2):147-51. PubMed ID: 10933124 [TBL] [Abstract][Full Text] [Related]